James Ermer
Impact in
- Psychiatry and Mental health top 5%
- Attention Deficit Hyperactivity Disorder
- Bipolar Disorder and Treatment
- Toxicology top 10%
Papers in
-
- Attention Deficit Hyperactivity Disorder 12
- Bipolar Disorder and Treatment 5
-
- Pharmacogenetics and Drug Metabolism 5
- Inflammatory mediators and NSAID effects 4
- Co-authors
- Patrick Martin (13 shared papers)Gary M. Pollack (2 shared papers)Danny D. Shen (2 shared papers)Michael Pennick (3 shared papers)Mary Corcoran (11 shared papers)Mary Buckwalter (4 shared papers)Glen Frick (1 shared paper)Ben Adeyi (2 shared papers)
- Journals
- Clinical Pharmacology & Therapeutics (5 papers)Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (3 papers)The Journal of Clinical Pharmacology (3 papers)Therapeutic Drug Monitoring (2 papers)European Neuropsychopharmacology (2 papers)
- Partner nations
- United StatesCanadaJapan
In The Last Decade
James Ermer
45 papers receiving 637 citations
Peers
Comparison fields: 5 of 89
- Psychiatry and Mental health 284
- Toxicology 27
- Cellular and Molecular Neuroscience 122
- Biological Psychiatry 13
- Pediatrics, Perinatology and Child Health 90
Countries citing papers authored by James Ermer
This map shows the geographic impact of James Ermer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Ermer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Ermer more than expected).
Fields of papers citing papers by James Ermer
This network shows the impact of papers produced by James Ermer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Ermer. The network helps show where James Ermer may publish in the future.
Co-authors
The 25 scholars most cited alongside James Ermer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1985 | 79 | |
| 2 | 2010 | 64 | |
| 3 | 2016 | 52 | |
| 4 | 2010 | 32 | |
| 5 | 2011 | 31 | |
| 6 | 2009 | 29 | |
| 7 | 2000 | 27 | |
| 8 | 1986 | 25 | |
| 9 | 2003 | 23 | |
| 10 | 2011 | 19 | |
| 11 | 2007 | 19 | |
| 12 | 2003 | 17 | |
| 13 | 2013 | 17 | |
| 14 | 2015 | 16 | |
| 15 | 2013 | 15 | |
| 16 | 2013 | 15 | |
| 17 | 2003 | 15 | |
| 18 | 2014 | 14 | |
| 19 | 2013 | 13 | |
| 20 | 1985 | 13 |
About James Ermer
James Ermer is a scholar working on Psychiatry and Mental health, Pharmacology, Genetics, Small Animals and Pharmacology, having authored 45 papers that have together received 662 indexed citations. Recurring topics across this work include Attention Deficit Hyperactivity Disorder (12 papers), Estrogen and related hormone effects (7 papers), Bipolar Disorder and Treatment (5 papers), Pharmacogenetics and Drug Metabolism (5 papers), Inflammatory mediators and NSAID effects (4 papers), Veterinary medicine and infectious diseases (4 papers), Bone health and osteoporosis research (3 papers) and Neurotransmitter Receptor Influence on Behavior (3 papers). The work is most often cited by research in Psychiatry and Mental health (284 citations), Toxicology (27 citations), Cellular and Molecular Neuroscience (122 citations), Biological Psychiatry (13 citations) and Pediatrics, Perinatology and Child Health (90 citations). James Ermer has collaborated with scholars based in United States, Canada and Japan. Frequent co-authors include Patrick Martin, Gary M. Pollack, Danny D. Shen, Michael Pennick, Mary Corcoran, Mary Buckwalter, Glen Frick, Ben Adeyi, Michael L. Pucci and Gayle P. Orczyk. Their work appears in journals such as Clinical Pharmacology & Therapeutics, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, The Journal of Clinical Pharmacology, Therapeutic Drug Monitoring and European Neuropsychopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.